Improvement of spinal inflammation in Ankylosing spondylitis (AS) by infliximab therapy as assessed by a magnetic resonance Imaging (MRI) using a novel evaluated spinal scoring system - Results of a double-blind placebo-controlled trial.

被引：0
|
作者：
Braun, J
Baraliakos, X
Golder, W
Listing, J
Brandt, J
Bollow, M
Sieper, J
van der Heijde, D
机构：
[1] Rheumazentrum Ruhrgebiet, Herne, Germany
[2] Free Univ Berlin, D-1000 Berlin, Germany
[3] Free Univ Herne, Herne, Germany
[4] Univ Hosp, Maastricht, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S426 / S427
页数：2
相关论文
共 50 条
  • [31] A double-blind, placebo-controlled trial of interferon β-1b in secondary progressive multiple sclerosis:: Magnetic resonance imaging results
    Miller, DH
    Molyneux, PD
    MacManus, DG
    Barker, GJ
    Wagner, K
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 503 - 504
  • [32] Effect of DA-9701 on Gastric Motor Function Assessed by Magnetic Resonance Imaging in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial
    Min, Yang Won
    Min, Byung-Hoon
    Kim, Seonwoo
    Choi, Dongil
    Rhee, Poong-Lyul
    PLOS ONE, 2015, 10 (09):
  • [33] Dual enhancing effects of motilitone on gastric accommodation and emptying assessed by magnetic resonance imaging in healthy volunteers: a randomized, double-blind, placebo-controlled Trial
    Min, Y. W.
    Min, B-H
    Kim, S.
    Choi, D.
    Rhee, P-L
    NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 : 3 - 3
  • [34] EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS REFRACTORY TO BIOLOGIC THERAPY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
    Van der Heijde, D.
    Baraliakos, X.
    Sieper, J.
    Deodhar, A.
    Inman, R.
    Kameda, H.
    Zeng, X.
    Sui, Y.
    Bu, X.
    Pangan, A.
    Wung, P.
    Song, I. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 402 - 403
  • [35] Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoring
    Beals, Chan
    Baumgartner, Richard
    Peterty, Charles
    Balanescu, Andra
    Mirea, Gavrila
    Harabagiu, Alexandru
    Popa, Serghei
    Cheng, Amy
    Feng, Dai
    Ashton, Edward
    DiCarlo, Julie
    Vallee, Marie-Helene
    Dardzinski, Bernard J.
    PLOS ONE, 2017, 12 (12):
  • [36] Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo-controlled GO-RAISE study (vol 71, pg 878, 2012)
    Braun, J.
    Baraliakos, X.
    Hermann, K-G A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (05) : 788 - 788
  • [37] The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis - Results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial
    Clair, EWS
    Wagner, CL
    Fasanmade, AA
    Wang, B
    Schaible, T
    Kavanaugh, A
    Keystone, EC
    ARTHRITIS AND RHEUMATISM, 2002, 46 (06): : 1451 - 1459
  • [38] Adalimumab reduces spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis (AS) - 52 week magnetic resonance imaging (MRI) results from the Canadian AS study
    Lambert, R. G. W.
    Salonen, D.
    Rahman, P.
    Inman, R.
    Wong, R.
    Patra, K.
    Thomson, G. T. D.
    Beaulieu, A.
    Choquette, D.
    Maksymowych, W. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 65 - 65
  • [39] Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: Results of a double-blind randomized placebo-controlled trial
    Silva, C
    Silva, J
    Ribeiro, MJ
    Avelino, A
    Cruz, F
    EUROPEAN UROLOGY, 2005, 48 (04) : 650 - 655
  • [40] Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab
    Sieper, J
    Baraliakos, X
    Listing, J
    Brandt, J
    Haibel, H
    Rudwaleit, M
    Braun, J
    RHEUMATOLOGY, 2005, 44 (12) : 1525 - 1530
12345